Gold has vast experience of the production of sterile injectable pharmaceuticals
Vanrx Pharmasystems has appointed Paul Gold to its Board of Directors.
Gold is an expert in the production of sterile injectable pharmaceuticals.
His most recent position was Director of Global Aseptic Technology for Pfizer Global Technology Services. After retiring from a 39-year career in the pharmaceutical industry, Gold founded Pamigo Aseptic, a consultancy focusing on aseptic pharmaceutical manufacturing.
'Paul brings extensive experience in aseptic processing operations to our board of directors. He will help us accelerate the adoption of our technologies for fill-finish and provide critical ‘voice-of-customer’ guidance to maximise the value of our product roadmap,' said Chris Procyshyn, Chief Executive Officer of Vanrx Pharmasystems.
Among Gold’s accomplishments is the co-invention of the Restricted Access Barrier System (RABS), a method for aseptic process separation and protection used globally in drug production facilities. His areas of expertise include sterile suspension processing, formulation development, equipment design, and product and process development for aseptically-produced sterile products.
Gold holds a Master of Science (Synthetic Organic Chemistry) from the University of Wisconsin, and a Bachelor of Science in chemistry from the State University of New York at Albany.